» Articles » PMID: 22474519

Effect of GCSB-5, a Herbal Formulation, on Monosodium Iodoacetate-Induced Osteoarthritis in Rats

Overview
Date 2012 Apr 5
PMID 22474519
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Therapeutic effects of GCSB-5 on osteoarthritis were measured by the amount of glycosaminoglycan in rabbit articular cartilage explants in vitro, in experimental osteoarthritis induced by intra-articular injection of monoiodoacetate in rats in vivo. GCSB-5 was orally administered for 28 days. In vitro, GCSB-5 inhibited proteoglycan degradation. GCSB-5 significantly suppressed the histological changes in monoiodoacetate-induced osteoarthritis. Matrix metalloproteinase (MMP) activity, as well as, the levels of serum tumor necrosis factor-α, cyclooxygenase-2, inducible nitric oxide synthase protein, and mRNA expressions were attenuated by GCSB-5, whereas the level of interleukin-10 was potentiated. By GCSB-5, the level of nuclear factor-κB p65 protein expression was significantly attenuated but, on the other hand, the level of inhibitor of κB-α protein expression was increased. These results indicate that GCSB-5 is a potential therapeutic agent for the protection of articular cartilage against progression of osteoarthritis through inhibition of MMPs activity, inflammatory mediators, and NF-κB activation.

Citing Articles

Effects of Combined Shinbaro and Celecoxib in a Complete Freund's Adjuvant-Induced Inflammatory Pain Mouse Model.

Jang J, Song Y, Han S, Choi B, Lee Y, Ha I J Inflamm Res. 2025; 18:2349-2362.

PMID: 39991659 PMC: 11844300. DOI: 10.2147/JIR.S500345.


Pharmacopuncture therapy for adhesive capsulitis: A pragmatic randomized controlled pilot study.

Kim D, Park K, Kim S, Seo J, Cho H, Lee Y Integr Med Res. 2024; 13(3):101065.

PMID: 39224580 PMC: 11367127. DOI: 10.1016/j.imr.2024.101065.


Repeated epidural delivery of Shinbaro2: effects on neural recovery, inflammation, and pain modulation in a rat model of lumbar spinal stenosis.

Hong J, Yeo C, Kim H, Lee J, Jeon W, Lee Y Front Pharmacol. 2024; 15:1324251.

PMID: 38828447 PMC: 11140021. DOI: 10.3389/fphar.2024.1324251.


Medical treatment of osteoarthritis: botanical pharmacologic aspect.

Park J, Lee S J Rheum Dis. 2024; 31(2):68-78.

PMID: 38559799 PMC: 10973355. DOI: 10.4078/jrd.2023.0084.


Bone protective effect of sinomenine against monosodium iodoacetate induced knee and hip injury in rat model: an inflammatory pathway.

Lei Y, Hu X, Wen H, Deng Y, Jiang J, Zhao Q Acta Cir Bras. 2024; 39:e390924.

PMID: 38324802 PMC: 10852535. DOI: 10.1590/acb390924.


References
1.
Wong R, Rabie A . Effect of genistin on bone formation. Front Biosci (Elite Ed). 2009; 2(2):764-70. DOI: 10.2741/e136. View

2.
Chu S, Yang S, Lue K, Hsieh Y, Hsiao T, Lu K . The clinical significance of gelatinase B in gouty arthritis of the knee. Clin Chim Acta. 2003; 339(1-2):77-83. DOI: 10.1016/j.cccn.2003.09.008. View

3.
Sakano Y, Terada N, Ueda H, Fujii Y, Hamada Y, Akamatsu N . Histological study of articular cartilage in experimental rat knee arthritis induced by intracapsular injection of cationic polyethyleneimine. Med Electron Microsc. 2002; 33(4):246-57. DOI: 10.1007/s007950000025. View

4.
Bove S, Calcaterra S, Brooker R, Huber C, Guzman R, Juneau P . Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003; 11(11):821-30. DOI: 10.1016/s1063-4584(03)00163-8. View

5.
Ameye L, Chee W . Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006; 8(4):R127. PMC: 1779427. DOI: 10.1186/ar2016. View